CRISPR Therapeutics Market Sentiment

CRISPR Therapeutics AG

CRSPNASDAQ

Trade with Public

$49.99

N/A

마지막 업데이트: Nov 4, 5:26 AM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

실적: Q3 2026 실적이 월 11월 2nd에 개장 전 발표되었습니다.

CRISPR Therapeutics Market Sentiment - Benzinga

CRISPR Therapeutics Market Sentiment

Market sentiment signals for CRISPR Therapeutics (CRSP): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 19.5% short float

Options Flow— N/A

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

30 analysts

Options Flow (P/C)

—

Avg Consensus PT

$71

+40.6%

Highest Price Target

$120

+136.0%

Truist Securities

Lowest Price Target

$32

-37.1%

Morgan Stanley

Short Interest

19.5%

Declining — Bullish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Nov 3, 2026	Needham	Gil Blum—	+61.3%	$82 → $82	Maintained	Buy
Oct 15, 2026	UBS	Joon Lee—	+2.3%	$52	Initiate	Neutral
Aug 31, 2026	Citizens	Silvan Turkcan—	+57.4%	$80 → $80	Maintained	Market Outperform
Aug 31, 2026	Needham	Gil Blum—	+61.3%	$82 → $82	Maintained	Buy
Aug 25, 2026	Citizens	Silvan Turkcan—	+57.4%	$80 → $80	Maintained	Market Outperform
Aug 4, 2026	Citigroup	Yigal Nochomovitz—	+73.1%	$82 → $88	Maintained	Buy
Jul 8, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+57.4%	$80 → $80	Maintained	Buy
Jul 6, 2026	Citizens	Silvan Turkcan—	+57.4%	$80 → $80	Maintained	Market Outperform
May 13, 2026	Bernstein	William Pickering—	+10.1%	$50 → $56	Maintained	Market Perform
May 6, 2026	Citigroup	Yigal Nochomovitz—	+61.3%	$80 → $82	Maintained	Buy
Mar 17, 2026	Piper Sandler	Edward Tenthoff—	+116.4%	$105 → $110	Maintained	Overweight
Feb 17, 2026	Chardan Capital	Geulah Livshits—	+49.5%	$74 → $76	Maintained	Buy
Feb 13, 2026	TD Cowen	Tyler Van Buren—	-11.5%	$40 → $45	Maintained	Hold
Feb 13, 2026	Evercore ISI Group	Liisa Bayko—	+45.6%	$62 → $74	Maintained	Outperform
Feb 13, 2026	Needham	Gil Blum—	+61.3%	$80 → $82	Maintained	Buy
Jan 30, 2026	Citizens	Silvan Turkcan—	+57.4%	$86 → $80	Maintained	Market Outperform
Dec 23, 2025	Needham	Gil Blum—	+57.4%	$80 → $80	Maintained	Buy
Dec 23, 2025	Citizens	Silvan Tuerkcan—	+69.2%	$86 → $86	Maintained	Market Outperform
Nov 26, 2025	Chardan Capital	Geulah Livshits—	+45.6%	$82 → $74	Maintained	Buy
Nov 12, 2025	Citigroup	Yigal Nochomovitz—	+51.5%	$87 → $77	Maintained	Buy
Nov 11, 2025	RBC Capital	Luca Issi—	-1.7%	$42 → $50	Maintained	Sector Perform
Nov 11, 2025	Baird	Jack Allen —	-13.5%	$52 → $44	Maintained	Neutral
Nov 10, 2025	Needham	Gil Blum—	+57.4%	$81 → $80	Maintained	Buy
Oct 17, 2025	B of A Securities	Geoff Meacham—	+82.9%	$78 → $93	Maintained	Buy
Oct 10, 2025	Needham	Gil Blum—	+59.3%	$81 → $81	Maintained	Buy